On a conference call with analysts, Gilead walked through how a string of recent deals focused on cancer and autoimmune ...

"Section 232" national security levies won't apply to a wide array of drugs, meaning the "overall threat to the sector should ...

Colorado drugmaker Ambrosia Biosciences has landed $100 million to pursue an oral obesity drug it’s hoping can compete with a ...

Zee Business provides the latest business news such as Indian stock market news and Updates, sensex live news & nifty news. Check out the personal finance news from the world of business including BSE ...

Grifols GRF1.90%increase; green up pointing triangle said it plans an initial public offering of its U.S. biopharma business, as the Spanish pharmaceutical company seeks to raise money to bolster its ...

The logo of the Spanish pharmaceuticals company Grifols is pictured on theirs facilities in Parets del Valles, north of Barcelona, Spain, January 9, 2024. REUTERS/Albert Gea March 24 (Reuters) - ...

TORONTO, March 10, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma ” or the “Company ”), is pleased to announce that it will release its ...

Biliary Tract Cancer Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced the appointment of John A. Orwin as Chair of its Board of Directors. Mr. Orwin ...

Synthekine Inc., an engineered cytokine therapeutics company, today announced the appointment of John A. Orwin as Chair of its Board of Directors. Mr. Orwin succeeds Srinivas Akkaraju, M.D., Ph.D., ...

Just as a disciplined a soccer player might pass on a hopeful shot in favor of a better chance later on, the biopharma venture capital market reflected a preference for de-risked assts over platforms ...

Nirmala Sitharaman introduced a new scheme "Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology and Innovation" with an outlay of INR 10,000 Cr for five years to boost ...